Recombinant SARS-CoV-2 Proteins
The spread of the 2019 new Coronavirus (SARS-CoV-2) throughout the world has a strong impact on our daily life and the fight against COVID-19 is one of the most important tasks of the scientific world in these days.
To support COVID-19 research, we produce ready-to-use recombinant SARS-CoV-2 proteins which can be used as antigen for analytic and immunodiagnostic purposes as well as for vaccine development.
Catalog of Recombinant SARS-CoV-2 Proteins
Our catalog of ready-to-use SARS-CoV-2 (COVID-19) proteins comprises SARS-COV-2 S, S1 RBD, N, M, 3CL-Mpro and other relevant proteins that are associated with Coronavirus infection. All proteins can be ordered from stock and have very short delivery times.
Background to the new Coronavirus SARS-CoV-2
One of the most important SARS-CoV-2 proteins for coronavirus research is the surface membrane protein Spike Glycoprotein (S). It is known to mediate the entry of the virus into human respiratory epithelial cells by interacting with the human cell surface receptor Angiotensin Converting Enzyme 2 (ACE-2).
The Spike S protein of SARS-CoV-2, the receptor binding domain (RBD) of SARS-CoV-2 Spike S1 protein and the human ACE-2 protein are crucial targets in COVID-19 research for the development of therapeutic antibodies, vaccines and serological tests. In addition, other structural and non-structural SARS-CoV-2 proteins play a relevant role in COVID-19 infection like the SARS-CoV-2 Proteinase 3 CL-Mpro (controlling the activities of the coronavirus replication complex), the SARS-CoV-2 M protein (defining the shape of the virus) and the Nucleocapsid (N) protein (important for viral replication).
Our R&D is continuously working with high priority on producing further relevant recombinant SARS-CoV-2 proteins for COVID-19 research. Due to optimized production process, we also offer bulk quantities up to gram scale.
If you want to discuss your planned COVID-19 research project directly with our scientific experts or if you have any customized inquiries or suggestions for SARS-CoV-2 related protein development, please do not hesitate to contact us.
Reinhold Horlacher, PhD
Managing Director & CSO
We would be happy to provide you with support on your protein research project. Let us know your questions and requests, our scientific experts will reply shortly.
Get In Contact With Our Scientific Experts